Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124812093 | 12481209 | 3 | F | 201508 | 20160712 | 20160620 | 20160719 | EXP | US-BIOGEN-2016BI00253126 | BIOGEN | 59.14 | YR | F | Y | 0.00000 | 20160719 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124812093 | 12481209 | 1 | PS | AVONEX | INTERFERON BETA-1A | 1 | Intramuscular | 103628 | 30 | UG | SOLN FOR INJECT IN PRE-FILLED SYRINGE | /wk | |||||||
| 124812093 | 12481209 | 2 | C | GABAPENTIN. | GABAPENTIN | 1 | Oral | 0 | 800 | MG | TABLETS | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124812093 | 12481209 | 1 | Multiple sclerosis |
| 124812093 | 12481209 | 2 | Optic nerve injury |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124812093 | 12481209 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124812093 | 12481209 | Hypoaesthesia | |
| 124812093 | 12481209 | Multiple sclerosis relapse | |
| 124812093 | 12481209 | Paraesthesia | |
| 124812093 | 12481209 | Sensory loss |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124812093 | 12481209 | 1 | 19981001 | 0 | ||
| 124812093 | 12481209 | 2 | 2004 | 0 |